文献速递妇科

子宫内膜癌分子亚型的种族差异

Racial disparities in molecular subtypes of endometrial cancer.
PubMed 文献 · Gynecol Oncol · 2018-01-01

该研究基于癌症基因组图谱(TCGA)数据,评估黑人与白人子宫内膜癌患者在分子亚型上的种族差异及其与无进展生存期(PFS)的关联。结果显示,侵袭性分子亚型(CNV-high、cluster 4、mitotic)在黑种患者中更常见,且这些亚型在黑人患者中提示更差的PFS,有丝分裂信号富集模式可能代表治疗机会。

要点

  • CNV-high亚型在黑种患者中占61.9%,白种患者中占23.5%(P=0.0005)。
  • Cluster 4亚型在黑种患者中占56.8%,白种患者中占20.9%(P<0.0001)。
  • Mitotic亚型在黑种患者中占64.1%,白种患者中占33.7%(P=0.002)。

核心结论

  • 来自TCGA的侵袭性分子亚型在黑种子宫内膜癌患者中更常见,且在黑人和白人患者中均提示更差的PFS。
  • Mitotic亚型在伴有子宫内膜样组织学的黑人患者中也提示更差的PFS。
  • 有丝分裂信号的富集模式可能代表治疗机会。

研究设计与样本

  • 研究获取了癌症基因组图谱(TCGA)的分子、临床和PFS数据,包括整合分型、体细胞拷贝数变异分型和基于转录的分型。
  • 共纳入337例患者,其中14%自认为黑人,27%为晚期,82%为子宫内膜样组织学。
  • 在黑人和白人患者中评估了侵袭性分子亚型(拷贝数变异[CNV]-high、cluster 4或mitotic)的患病率和预后价值。

主要发现

  • CNV-high亚型在黑种患者中占61.9%,白种患者中占23.5%(P=0.0005),在黑人患者中提示更差的PFS(风险比[HR]=3.4,P=0.189)。
  • Cluster 4亚型在黑种患者中占56.8%,白种患者中占20.9%(P<0.0001),在黑人患者中与更差的PFS相关(HR=3.4,P=0.049)。
  • Mitotic亚型在黑种患者中占64.1%,白种患者中占33.7%(P=0.002),在黑人患者中提示更差的PFS(HR=4.1,P=0.044),包括子宫内膜样组织学(HR=6.1,P=0.024),并表现出与种族相关的细胞周期信号和癌症通路富集,包括PLK1和BIRC7。
  • 所有上述侵袭性分子亚型在白人患者中也提示更差的PFS,但具有与黑人患者不同的有丝分裂信号独特富集。

关键数值与推荐

  • CNV-high亚型患病率:黑人患者61.9%,白人患者23.5%(P=0.0005)。
  • Cluster 4亚型患病率:黑人患者56.8%,白人患者20.9%(P<0.0001)。
  • Mitotic亚型患病率:黑人患者64.1%,白人患者33.7%(P=0.002)。
  • 黑人患者中,CNV-high亚型的PFS HR=3.4(P=0.189),cluster 4亚型的PFS HR=3.4(P=0.049),mitotic亚型的PFS HR=4.1(P=0.044),子宫内膜样组织学中mitotic亚型的PFS HR=6.1(P=0.024)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Racial differences in the molecular subtypes of endometrial cancer and associations with progression-free survival (PFS) were evaluated. METHODS: Molecular, clinical and PFS data were acquired from the Cancer Genome Atlas (TCGA) including classification into the integrative, somatic copy number alteration and transcript-based subtypes. The prevalence and prognostic value of the aggressive molecular subtypes (copy number variant [CNV]-high, cluster 4 or mitotic) were evaluated in Black and White patients. RESULTS: There were 337 patients including 14% self-designated as Black, 27% with advanced stage, and 82% with endometrioid histology. The CNV-high subtype was more common in Black than White patients (61.9% vs. 23.5%, P=0.0005) and suggested worse PFS in Black patients (hazard ratio [HR]=3.4, P=0.189). The cluster 4 subtype was more prevalent in Black patients (56.8% vs. 20.9%, P<0.0001) and associated with worse PFS in Black patients (HR=3.4, P=0.049). The mitotic subtype was more abundant in Black patients (64.1% vs. 33.7%, P=0.002), indicated worse PFS in Black patients (HR=4.1, P=0.044) including the endometrioid histology (HR=6.1, P=0.024) and exhibited race-associated enrichment in cell cycle signaling and pathways in cancer including PLK1 and BIRC7. All of these aggressive molecular subtypes also indicated worse PFS in White patients, with unique enrichments in mitotic signaling different from Black patients. CONCLUSIONS: The aggressive molecular subtypes from TCGA were more common in Black endometrial cancer patients and indicated worse PFS in both Black and White patients. The mitotic subtypes also indicated worse PFS in Black patients with endometrioid histology. Enrichment patterns in mitotic signaling may represent therapeutic opportunities.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Dubil EA, Tian C, Wang G, et al. Racial disparities in molecular subtypes of endometrial cancer. Gynecol Oncol. 2018. PMID: 29605044. doi:10.1016/j.ygyno.2017.12.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。